Welcome to our dedicated page for Claritev news (Ticker: CTEV), a resource for investors and traders seeking the latest updates and insights on Claritev stock.
Claritev Corporation (NYSE: CTEV) is a healthcare technology, data and insights company that regularly issues news on its role in improving healthcare affordability, transparency and quality. As a health information services and healthcare technology provider, Claritev uses AI-driven analytics and decades of claims experience to support payors, employers, providers, patients and third parties across the healthcare ecosystem. Its news flow reflects both operating performance and strategic initiatives tied to this mission.
On this page, readers can follow Claritev news related to quarterly financial results, investor presentations and participation in major healthcare and finance conferences. The company frequently announces earnings for periods such as its third quarter, along with updates on revenues, net income or loss, Adjusted EBITDA and other financial metrics. These releases often include commentary on business momentum, guidance updates and the scale of claim charges processed and potential medical cost savings identified.
Claritev also publishes news about client relationships and contracts, including renewals with its largest clients and information about multi-year agreements that cover a significant share of its revenues. In addition, the company highlights strategic partnerships and international initiatives, such as agreements to deliver AI-powered revenue cycle management platforms in the Middle East and North Africa and investments in healthcare payment-acceleration providers that connect its U.S. presence with activity in the MENA region.
Other Claritev announcements include brand and sponsorship activities, such as golf sponsorships with professional players that the company positions as ambassadors for its values. For investors, analysts and observers of the healthcare technology sector, this news page provides a centralized view of Claritev’s public disclosures, from financial updates and capital markets transactions to technology collaborations and market expansion efforts.
Claritev (NYSE: CTEV) announced on November 12, 2025 that certain affiliates of Hellman & Friedman are commencing an underwritten public offering of 1,500,000 shares of Class A common stock, with underwriters granted a 30‑day option to purchase up to an additional 225,000 shares.
Claritev will not sell any shares in the Offering and will not receive proceeds. The underwriters propose to offer the shares to the public at a fixed price that may change. The Offering is subject to market and other conditions and a prospectus supplement will be filed with the SEC.
Claritev (NYSE: CTEV) reported Q3 2025 results with revenues of $246.0 million, up 6.7% year-over-year, and an Adjusted EBITDA of $155.1 million (margin 63.1% vs 61.5% in Q3 2024).
The company recorded a net loss of $69.8 million for Q3 2025 versus a net loss of $391.5 million in Q3 2024. Q3 net cash from operations was $19.9 million and Free Cash Flow was $(16.3) million. Cash and cash equivalents were $39.2 million at quarter end.
Claritev processed ~$45.9 billion in claim charges in Q3, identifying ~$6.1 billion of potential medical cost savings. The company updated FY2025 guidance to revenues +2.8%–3.2% vs FY2024, maintained Adjusted EBITDA margin guidance at 62.5%–63.0%, and reduced capex to $165M–$175M.
Claritev (NYSE: CTEV) announced a strategic investment in Klaim, Inc. to launch a co-branded Payment Acceleration Service across the U.S. and MENA regions on October 27, 2025. The platform combines Claritev’s ACE claim-coding analytics and provider network with Klaim’s AI payment-acceleration technology to convert pending insurance claims into near-instant liquidity, shortening the typical 30–120 day reimbursement cycle.
Key aims include faster, more predictable reimbursements, reduced administrative burden, flexible claim-volume usage, and scalable access for clinics to large hospitals. Klaim also announced a planned global restructuring to unify its Middle East and U.S. operations under a global holding company.
Claritev (NYSE: CTEV) will release its third quarter 2025 financial results on Friday, November 7, 2025 and hold a conference call the same morning at 8:00 AM Eastern Time.
Investors can pre-register for the call via the provided NetRoadshow link to receive a unique PIN and calendar invite; pre-registration remains open up to and after the call start time. A live webcast, supplemental slide deck and the earnings press release will be available in the Investor Relations section at investors.claritev.com/events-and-presentations, and a replay will be archived there after the call.
Claritev (NYSE: CTEV) announced an exclusive strategic agreement with iO Health to license, integrate, and resell iO Health’s Optima AI platform across the Middle East and North Africa (MENA).
The partnership will integrate Optima AI into Claritev’s product suite to target claim-denial reduction, workflow optimization, and improved financial and clinical decision-making for hospitals, clinics, and payors. The companies will collaborate on implementation, integration, and ongoing support to deploy the technology regionally.
The agreement is positioned as a key step in Claritev’s global expansion strategy and aims to accelerate revenue recovery and operational efficiency for MENA healthcare organizations.
Claritev (NYSE:CTEV), a healthcare technology and insights company, has expanded its golf sponsorship portfolio by renewing its agreement with Neal Shipley and adding three new ambassadors: Bud Cauley, Ryan Fox, and Darren Clarke.
The roster includes promising talent Shipley (24), who earned low amateur honors at both the Masters and U.S. Open, PGA TOUR veteran Cauley, New Zealand's Fox with multiple international victories including two PGA TOUR wins, and major champion Clarke who now competes on the PGA Tour Champions.
The sponsorships align with Claritev's mission of making healthcare more affordable, transparent, and fair, partnering with athletes who demonstrate excellence and resilience in their careers.
Claritev (NYSE:CTEV), a healthcare technology and data insights company, has achieved the Great Place To Work® Certification™ for the fourth consecutive year and made Fortune's Best Workplaces in Health Care™ list for the third consecutive year. The certification reflects strong employee satisfaction, with 76% of employees rating it as a great workplace - 19 points above the U.S. average.
Key survey highlights include 87% of employees contributing to strategic priorities, 90% feeling welcomed upon joining, and 85% affirming ethical management practices. According to Great Place To Work® research, certified workplaces show significantly higher employee satisfaction, with workers being 93% more likely to look forward to work and twice as likely to receive fair compensation and advancement opportunities.
Claritev Corporation (NYSE:CTEV), a healthcare technology and data insights company, has announced its participation in two major healthcare conferences in September 2025.
Management will attend the 2025 Wells Fargo Healthcare Conference on September 3 in Boston, featuring a presentation at 8:45 AM ET, and the Morgan Stanley 23rd Annual Global Healthcare Conference on September 9 in New York, with a fireside chat scheduled for 4:05 PM ET. Both events will be accessible via webcast through Claritev's investor relations website.
Claritev Corporation (NYSE:CTEV) reported its Q2 2025 financial results, showing signs of growth with revenues of $241.6 million, up 3.5% year-over-year. Despite posting a net loss of $62.6 million, the company achieved an Adjusted EBITDA of $154.0 million with a strong margin of 63.8%.
The company demonstrated operational efficiency by processing $43.8 billion in claim charges and identifying potential medical cost savings of $6.3 billion. Free Cash Flow improved significantly to $36.6 million, compared to $(7.0) million in Q2 2024.
Claritev updated its full-year 2025 guidance, now projecting revenue growth of flat to +2% (improved from previous -2% to flat), and revised Free Cash Flow expectations to range between $(20) million to $20 million. Capital expenditure guidance was increased to $170-180 million.
Claritev (NYSE:CTEV) has announced its integration with athenahealth's Marketplace program, making its CompleteVue™ platform available to athenahealth's network of over 160,000 healthcare providers.
CompleteVue™ transforms price transparency data into actionable insights through comprehensive market analyses, real-time pricing simulations, clinical normalization, and proprietary Data Usability Ratings. The platform aims to strengthen healthcare providers' financial performance by providing data-driven negotiation strategies and contract optimization tools.
The integration will enable athenaOne customers to access CompleteVue's analytics capabilities, helping providers optimize revenue while reducing costs in an otherwise opaque healthcare pricing market.